Tag: SNM

Axonics two year results ARTISAN-SNM study

Axonics granted six US patents and allowed three additional patents related...

Axonics has announced that the United States Patent and Trademark Office has issued or allowed Axonics nine US utility patents in 2019, along with...
Axonics two year results ARTISAN-SNM study

Axonics provides survey results from Physician Seminar Series showcasing the recently...

  Axonics, a medical technology company that has developed and is commercialising novel implantable Sacral Neuromodulation (SNM) devices for the treatment of bladder and bowel...
SNM axonics system

Axonics announces first commercial US patient implanted with its sacral neuromodulation...

  Axonics has announced the first US-based implantation of the Axonics r-SNM system subsequent to its clearance by the US Food & Drug Administration (FDA)...
Axonics FDA approval Remote Control

Axonics announces agreement to supply sacral neuromodulation systems to leading urology...

  Axonics has announced that it has entered into an exclusive agreement to supply the Axonics rechargeable sacral neuromodulation (r-SNM) system to Adult Pediatric Urology...